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Oxidative stress plays an essential role in the pathogenesis of chronic diseases such as
cardiovascular diseases, diabetes, neurodegenerative diseases, and cancer. Long term
exposure to increased levels of pro-oxidant factors can cause structural defects at a
mitochondrial DNA level, as well as functional alteration of several enzymes and cellular
structures leading to aberrations in gene expression. The modern lifestyle associated
with processed food, exposure to a wide range of chemicals and lack of exercise
plays an important role in oxidative stress induction. However, the use of medicinal
plants with antioxidant properties has been exploited for their ability to treat or prevent
several human pathologies in which oxidative stress seems to be one of the causes.
In this review we discuss the diseases in which oxidative stress is one of the triggers
and the plant-derived antioxidant compounds with their mechanisms of antioxidant
defenses that can help in the prevention of these diseases. Finally, both the beneficial
and detrimental effects of antioxidant molecules that are used to reduce oxidative stress
in several human conditions are discussed.
Keywords: reactive oxygen species, oxidative stress, natural antioxidants, neurological disorders, cardiovascular
diseases, cancer, aging, antioxidant defense
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INTRODUCTION
Many natural biological processes in our bodies, such as
breathing, digesting food, metabolize alcohol and drugs, and
turning fats into energy produce harmful compounds called free
radicals. Free radicals are usually destroyed by our body’s natural
antioxidant system. If this system an not cope properly, free
radicals can trigger a negative chain reaction in the body, a
reaction that can destroy the cell membrane, block the action of
major enzymes, prevent cellular processes necessary for proper
functioning of the body, prevent normal cell division, destroy
deoxyribonucleic acid (DNA), and block energy generation
(Kurutas, 2015).
Oxidative stress is reported to associate with the development
of several metabolic, chronic disorders or cancers (Finkel and
Holbrook, 2000; Reuter et al., 2010; Aminjan et al., 2019).
The theory of free radicals of oxygen has been known for over
50 years, however, it is only in the last two decades that their
role in the development of diseases were discovered and, thus,
the beneficial effects of antioxidants have been widely studied
(Liu, 2019).
Free radicals play an essential role in several biological
processes. Many of these are necessary for life, such as the
intracellular destruction of bacteria by phagocytes, especially
by granulocytes and macrophages. Researchers believe that free
radicals are also involved in some cellular signaling processes,
known as redox signaling (Finkel and Holbrook, 2000). At low-
to-moderate amounts, ROS are beneficial both in regulating
processes involving the maintenance of homeostasis as well as
a wide variety of cellular functions (Finkel and Holbrook, 2000;
Bhattacharyya et al., 2014).
Excessive ROS production determines structural modification
of cellular proteins and the alteration of their functions, leading
to cellular dysfunction and disruption of vital cellular processes
(Finkel and Holbrook, 2000; Kaminski et al., 2002). High ROS
levels cause lipid, protein, and DNA damage. In particular,
ROS can break the lipid membrane and increase membrane
fluidity and permeability. Protein damage involves site-specific
amino acid modification, peptide chain fragmentation, cross-
linked reaction products aggregation, electric charge alteration,
enzymatic inactivation, and proteolysis susceptibility (Ayala
et al., 2014). Finally, ROS can damage DNA through oxidizing
deoxyribose, breaking strand, removing nucleotides, modifying
bases and crosslinking DNA-protein (Sharma et al., 2012; Cadet
and Wagner, 2013; Cadet et al., 2017; Liang et al., 2020).
Primary oxygen free radicals are superoxide and hydroxyl
radical. They are derived from molecular oxygen under chemical
reduction conditions. Excessive amounts of these free radicals
can lead to cell damage and apoptosis, contributing to many
diseases such as cancer, stroke (Tsatsakis A. et al., 2019),
myocardial infarction, diabetes, and other significant conditions
(Padureanu et al., 2019). Many cancers are thought to be the
result of interactions between free radicals and DNA that lead
to mutations that affect the cell cycle and which then leads to
neoplasia (Reuter et al., 2010).
Because free radicals are necessary for life, the body has several
enzymatic mechanisms to minimize radically induced damage
and to protect against excessive production of free radicals.
Antioxidants play a vital role in these defense mechanisms.
In healthy organisms, protection against the harmful effects of
reactive oxygen species is achieved by maintaining a delicate
balance between oxidants and antioxidants. The continuous
production of free radicals in aerobic organisms must therefore
be equalized by a similar rate of antioxidant consumption.
Enzymatic or non-enzymatic, antioxidants are substances that
prevent the formation of free radicals, and seek and neutralize
or repair the damage caused by them (Clark et al., 1985).
The protection against oxidative damage and chronic diseases
is achieved through a variety of endogenous and exogenous
antioxidants (Cadet et al., 2012).
ROS homeostasis is ensured by various antioxidant systems
present both in plants (Sharma et al., 2012) and the human
body (Birben et al., 2012). Natural ROS production through
the mitochondrial respiratory chain is involved since ROS can
be metabolically beneficial, but, at the same time, harmful to
cells in some conditions (Hsu et al., 2000; Poli et al., 2004;
Valko et al., 2006).
Conversely, in pathological or stress conditions, ROS
overwhelms antioxidant systems leading to an imbalance, which,
in turn, causes oxidative stress and irreversible changes in
cell compounds, including proteins, carbohydrates and lipids,
in addition to being able to disrupt normal cellular-signaling
mechanisms (Birben et al., 2012; Zal et al., 2014; Salehi et al., 2018;
Sharifi-Rad et al., 2018).
In autoimmune diseases, free radicals can change the
expression of self-antigen-type proteins, increasing their immune
response or changing their antigenic profile. The immune
response can also be influenced by external antioxidants
such as allergens in susceptible individuals. Pollen from
some plant species has been shown to contain nicotinamide
adenine dinucleotide phosphate oxidase (NADPH oxidase),
which induces an inflammatory response in the airways with
specific symptoms due to infiltration with proinflammatory
cytokines, TNF-alpha and interleukins from epithelial cells. The
appearance and accumulation of intracellular prooxidant factors
has the long-term effect of altering the immune response by
altering the structure and, implicitly, the function of proteins
or enzymes such as: interferon−gamma (IFN−γ), cluster of
differentiation antigen 14 (CD14), and tumor necrosis factor-a
(TNF-α) (Tsoukalas et al., 2019c).
In cancers, alteration of purine or pyrimidine in the structure
of cellular DNA, which is associated with a number of other
reactions that produce oxides and free radicals, may be the
cause of neoplasms. If the intracellular mechanisms of repair
of oxidative defects are insufficient or disturbed in turn by
the oxidative factors present, there are definitive consequences
in some genes or products resulting from the expression of
these genes, which causes mutagenesis and modification of the
apoptotic mechanism of the cell, thus resulting in the tumor cell
(Buj and Aird, 2018).
In the long term, the changes spread and self-sustain with
the permanent activation of the autoimmune response and the
accumulation of local proinflammatory factors, for example:
TNF-alpha, proteases, kinases. These factors favor tissue necrosis
and accelerate tissue growth with the appearance of new modified
cells that maintain the immune response and propagate the initial
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genetic defects with chaotic and extensive multiplication; also,
oxidative stress produces structural changes of cell membranes
with decreased adhesion, and the migration of altered tumor
cells in neighboring tissues or in distant blood and lymph
(Forni et al., 2019).
In cellular aging, two theories on the mechanisms of
cellular aging are currently accepted: the mitochondrial theory
and the free radical theory. They support the hypothesis
that mitochondria are affected by an increased level of
intracellular free radicals, which leads to the alteration of their
function and a decreased cellular regenerative capacity. At
the same time, the progressive accumulation of intracellular
oxidizing factors that exceed the antioxidant capacity is also
accepted. Under these conditions, the biological decline of the
respective tissue and the reduction of the adaptive c pacity
to stress appear. Subsequently, regardless of the mechanism
involved, in mitochondrial DNA damage or in the direct
involvement of prooxidant factors in cellular mechanisms, the
cellular response to stress will produce an overexpression of
proinflammatory genes with increasing levels of prooxidant
factors (Liguori et al., 2018).
Oxidative stress stimulates the immune response and
causes allergic diseases, such as asthma, allergic rhinitis,
atopic dermatitis, or food allergies. This means that the
antioxidant protection system of patients with allergic
diseases is outdated compared to that of healthy individuals
(Sackesen et al., 2008). Supplementation with antioxidants
could therefore compensate for the increased inflammatory
and oxidative stress processes in asthma patients. However,
Murr et al. (2005) have shown that too much antioxidant
supplementation can increase the susceptibility to allergic
diseases and thus asthma, by decreasing the Th1-type
immune response and increasing the Th2-type response
with immunoglobulin synthesis.
The modern lifestyle associated with an unhealthy diet, lack
of physical exercise, exposure to a combination of chemicals
from different sources pesticides (Tsatsakis A.M. et al., 2019),
heavy metals, food additives, and environmental pollution can
influence the appearance of oxidative stress. It can contribute
to the increasing burden of chronic diseases, as is suggested
by several experimental and human studies (Fenga et al., 2017;
Docea et al., 2018; Fountoucidou et al., 2019; Kostoff et al., 2020).
This comprehensive review aims to provide strong evidence
that antioxidants may contribute to the amelioration of some
chronic-degenerative conditions, in addition to being able to
promote healthy aging.
CHRONIC DISEASES INFLUENCED BY
ROS-MODALITIES OF ACTION
The ROS Sources
Free radicals are generally produced as a result of the influence of
external factors, such as pollution, cigarette smoke, or internally,
as a result of intracellular metabolism if the antioxidant
mechanisms are overwhelmed (Figure 1).
Exogenous ROS
Environmental triggers, such as exposure to cigarette smoke, UV
radiation, heavy metal ions, ozone, allergens, drugs or toxins,
pollutants, pesticides, or insecticides, may all contribute to the
increase of ROS production in cells (Antunes dos Santos et al.,
2018; Mahajan et al., 2018; Oke et al., 2019).
Ionizing radiation acts by converting hydroxyl radicals,
superoxides and organic radicals into organic hydroperoxides
and hydrogen peroxide. Subsequently, the peroxides react with
the metal ions of Fe and Cu at the cellular level through redox
reactions with secondary oxidative activity. Several studies have
shown that the exposure of fibroblasts to alpha particles has
led to an intracellular increase of oxygen and an accelerated
production of peroxide at this level (Spitz et al., 2004;
Spitz and Hauer-Jensen, 2014).
Ultraviolet radiation (UVA) triggers oxidative reactions by
stimulating riboflavin, porphyrins and NADPH-oxidase, with the
production of 8-oxo-guanine as the main result and the decrease
of intracellular glutathione (GSH) level with a return to normal
after cessation of exposure (Marchitti et al., 2011).
Heavy metals play an essential role in the production of
free radicals (Ściskalska et al., 2014). Iron, copper, cadmium,
nickel, arsenic, and lead can induce free radicals by Fenton
or Haber-Weiss type reactions, but also by direct reactions
between metal ions and cellular compounds with similar
effects – for example, the production of thiol type radicals.
Lead triggers lipid peroxidation and increases glutathione
peroxidase concentration in brain tissue. Arsenic induces
the production of peroxides, superoxides, nitric oxide and
inhibits antioxidant enzymes such as glutathione-transferase,
glutathione-peroxidase, and glutathione-reductase by binding to
the sulfhydryl group. The free radicals generated from these
reactions can affect DNA, with substitutions of some DNA
bases such as guanine with cytosine, guanine with thymine
and cytosine with thymine (Jan et al., 2015). Exposure to
ozone can affect lung function even in healthy individuals by
increasing inflammatory infiltrate in the respiratory epithelium
(Wu X. et al., 2019).
Endogenous ROS Production
The main endogenous sites of cellular redox-reactive species
generation-including ROS and reactive nitrogen species (RNS)
comprise mitochondrial electron transport chain (ETC),
endoplasmic reticulum (ER), peroxisomes, membrane-bound
NADPH oxidase (NOX) isoforms 1–5, dual oxidases (Duox)
1 and 2 complexes, and nitric oxide synthases isoforms 1–5
(NOS1–3). The complexes I and III of mitochondrial ETC
produces superoxide anion (Rodriguez and Redman, 2005).
The mitochondrial ETC is considered to be the primary
endogenous source of ROS but other internal sources are also
present. Other sources of ROS, primarily H2O2, are microsomes
and peroxisomes. Immune cells, such as macrophages and
neutrophils, can also generate ROS due to their oxygen-
dependent mechanisms to fight against invading microorganisms
based on NOX2 isoform (Curi et al., 2016). Furthermore,
dysregulated ROS signaling may contribute to a multitude of
diseases associated with oxidative stress (Finkel, 2011).
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FIGURE 1 | Schematic presentation of the sources of free radicals and their effects on the human body.
ROS are produced in mitochondria during aerobic
metabolism (Rodriguez and Redman, 2005). ROS generation
within mitochondria (oxidative metabolism) is closely associated
with ATP synthesis (oxidative phosphorylation). In aerobic
organisms, the coupling of these reactions is the primary source
of energy (Papa et al., 2012).
Mitochondria serve as a major ROS generator and, at
the same time, as a ROS receptor. Covalent and enzymatic
changes in proteins during or after protein biosynthesis as
well as during protein cleavage or degradation promote disease
through oxidative damage and mitochondrial dysfunction.
These post-translational changes participate in the regulation of
mitochondrial function through free radical species and other
messengers (Hu and Ren, 2016).
Since oxidative phosphorylation is a leaky process, 0.2–
5% of the electrons circulate through ETC in each round of
ATP production. This produces an incompletely O2 reduction
(Hamanaka et al., 2013).
Superoxide radicals are produced by NADPH oxidases (NOX)
and, to a minor extent, as by-products of a wide number
of metabolic enzymes such as cyclooxygenase (COX) 1/2,
lipoxygenase, xanthine oxidoreductase (XOR) and cytochrome
p450 (Finkel, 2003).
Because of the anionic properties of superoxide radicals,
they diffuse through biological lipid membranes at the meager
extent. They are sequentially reduced inside cells to form
hydrogen peroxide and hydroxyl radical (Bartosz, 2009).
Furthermore,peroxyl and alkoxyl radicals, as well as hypochlorite
ions, are also formed (Valko et al., 2007).
All these types of ROS can be very harmful to cells;
in fact, they can oxidize and subsequently inactivate several
functions of cell components and even DNA (Valko et al.,
2007). All these processes may trigger irreversible apoptotic and
necrotic cell death.
Several studies indicate that human cells can also actively
trigger ROS production at small doses, as part of signaling
pathways, regulating cell survival and proliferation, as a defense
mechanism against invaders (Bartosz, 2009; Sena and Chandel,
2012). In particular, specific enzymatic systems, such as the NOX
family, dedicated explicitly to superoxide radical production
with physiological signaling purposes, are developed by cells
(Bedard and Krause, 2007).
In normal situations, electrons are transferred through
mitochondrial ETC for oxygen reduction to water, but
approximately 1–3% of electrons escape from this system
and produce superoxide (Ramsay, 2019). Beyond this, other
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internally generated sources of ROS are present in humans,
including:
(i) oxidative burst from phagocytes (white blood cells) during
bacteria and virus killing and foreign proteins denaturation;
(ii) xanthine oxidoreductase (XOR) metabolism;
(ii) arachidonate pathways;
(iii) peroxisomes metabolism;
(iv) detoxification of toxic substances (i.e., vigorous exercise,
chronic inflammation, and infections) (Birben et al., 2012).
ROS decrease phosphatase activity, by inhibiting catalytic
regions susceptible to oxidation, and, thus, enhance protein
tyrosine phosphatase (PTP) phosphorylation and influences
signal transduction (Bedard and Krause, 2007). ROS can also
improve signal transduction pathways that disturb the nuclear
factor-κB (NF-κB) activation and translocation of this into
the nucleus. The DNA binding potential of oxidized NF-κB is
significantly reduced. However, NF-κB may be decreased by
TR or redox factor 1 (Kabe et al., 2005). The above provokes
ROS and RNS so it can strongly affect NF-κB-dependent
inflammatory signals. Cyclopentenones are electrophilic anti-
inflammatory prostaglandins which are conjugated with the
reactive thiols of ROS-modified peptides and proteins and
thus dampens ROS-mediated NF-κB signaling (Homem de
Bittencourt and Curi, 2001). On the other hand, endogenous
stress has an intracellular origin. Several studies have highlighted
the role of cultural cell conditions, altering gene expression
patterns of different genes and their DNA stability. Metabolic
processes trigger different types of ROS, that are able to, if
present at inadequate levels, oxidize DNA and induce various
damage, such as double-stranded DNA breaks and deficiencies,
often found in human tumors (De Bont and van Larebeke,
2004). Moreover, there are non-enzymatic reactions, like
the mitochondrial respiratory chain which involves NADPH
oxidase, XOR, uncoupled endothelial NOS, cytochrome P450
enzymes, lipoxygenase and COX (Sena and Chandel, 2012;
Battelli et al., 2014a).
Cellular oxidative metabolism produces free radicals and
organic peroxides as by-products during cellular mitochondrial
electron transport or through metal-catalyzed oxidation of
metabolites and oxidoreductases (Forman and Torres, 2002;
Hussain et al., 2016).
Moreover, nitric oxide is produced in hypoxic conditions in a
respiratory chain reaction, and RNS may trigger reactive species
production, such as reactive aldehydes, malondialdehyde (MDA)
and 4-hydroxy-2-non-enal (Hussain et al., 2016). ROS can alter
the cell’s redox status and, thus, send a signal. However, an
imbalance in this protective mechanism can lead to damage in
cell molecules, such as DNA, proteins and lipids, resulting in
cell death by necrotic and apoptotic processes (Bhattacharyya
et al., 2014; Hussain et al., 2016). Stimulated ROS production
was first described in phagocytic cells, including neutrophils
and macrophages, during phagocytosis or stimulation with a
wide variety of agents through NADPH oxidase activation. This
was named “the respiratory burst” due to transient oxygen
consumption (Lamy et al., 1996; Peake and Suzuki, 2004). The
respiratory burst of neutrophils, as well as their degranulation,
constitute a defensive response to host tissue damage, whether
induced by mechanical (muscle damage during exercise, thermal
stress), chemical or infectious stimuli (Lamy et al., 1996; Peake
and Suzuki, 2004).
Nowadays, ROS production has also been observed in a
variety of cells other than phagocytes, and their implication in
physiologic signaling is well documented (Di Meo et al., 2016).
The Role of Lifestyle in Oxidative Stress Response
Lifestyle: smoking, alcohol consumption, adequate or
inappropriate diet, exercise, training or untrained condition,
contribute to oxidative stress. Some research has shown the
presence of reactive oxygen species and muscle level and
their role in regulating muscle activity. Skeletal muscle fibers
continuously generate reactive oxygen species at a low level,
which increases during muscle contraction. They exert multiple
direct and indirect effects on muscle activity (contractility,
excitability, metabolism, and calcium homeostasis) and are
involved in skeletal muscle fatigue during strenuous exercise
(Pingitore et al., 2015).
Exhausting exercises, long exercises, overtraining syndrome,
and overcoming limits as a phase of the initial onset of
overtraining syndrome, induce a significant response to oxidative
stress. Instead, moderate exercise, low intensity training, and
prolonged training, improve endogenous antioxidant status.
Reactive oxygen species play an important role in cell signaling
and in regulating the expression of antioxidant genes. Physical
exertion produces a hyperregulation of the nuclear factor kappa
B and mitogen-activated protein kinase that activates gene
expression of a number of enzymes and proteins with an
important role in maintaining oxidative/antioxidant intracellular
homeostasis (Antonioni et al., 2019).
Physical exercise is considered the main treatment of non-
pharmacological therapies along with lifestyle changes for various
chronic diseases, especially cardiovascular diseases (Ren and
Taegtmeyer, 2015). The results of some experimental studies
have highlighted the role of autophagy, a conservative process
of catabolism for the degradation and recycling of cellular
organs and nutrients, in the cardiovascular benefits offered by
training (Wu N. N. et al., 2019). Regular exercise as a unique
form of physiological stress is able to trigger adaptation, while
autophagy, especially selective mitochondrial autophagy, also
called mitophagy, allows for such cardiovascular adaptation (Wu
N. N. et al., 2019).
Cigarette smoke comprises a series of oxidants, free radicals,
as well as organic components (e.g., nitric oxide and nitric
superoxide) where the lung level activates the accumulation of
neutrophils and macrophages, which increases the production of
oxidants locally (Valavanidis et al., 2009).
Biochemical/Molecular Targets and
Chronic Diseases Mechanistically Linked
to ROS
Endogenous ROS comprises the by-products of cellular
metabolism in aerobic organisms.
At low concentrations, they are usually involved in different
cell processes, such as proliferation, differentiation, and
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apoptosis, like a second messenger in cell signaling (Salehi
et al., 2018). ROS production within cells under physiological
condition is dependent on mitochondria respiration, NOX,
uncoupled NOS and XOR.
The increase in ROS levels, its production in inappropriate
cellular compartments or its production with defective forms
during oxidative processes can trigger the development of
numerous chronic-degenerative disorders, leading to severe
damage to bio macromolecules (Chen et al., 2012; Gandhi and
Abramov, 2012; Salehi et al., 2018). Oxidative stress, as a result
of the imbalance between oxidative and antioxidative processes
in cells, therefore plays an essential role in the pathogenesis of
numerous chronic-degenerative disorders.
ROS and Cardiovascular Diseases
The main cardiovascular risk factors, such as hypertension
and hypercholesterolemia contribute to enhancing ROS
generation, leading to oxidative stress (Li et al., 2014). From all
these cardiovascular risk factors, hypertension is an essential
factor in the development of cardiovascular diseases (CVD)
(Elahi et al., 2009).
ROS has a dual role in cardiovascular physiopathology.
Small amounts of ROS in the cardiovascular system
could provide remarkable benefits: anti-atherosclerotic,
pro-angiogenesis and endogenous cardioprotective effects
(Taverne et al., 2013). Large numbers of ROS induce the
loss of cell viability, since oxidative stress is involved in the
development and/or progression of CVD, such as endothelial
dysfunction, atherosclerosis, myocardial ischemia/reperfusion
damage, heart failure, arrhythmias (Taverne et al., 2013;
Sharifi-Rad J. et al., 2020).
In CVD, gene expression is altered due to oxidative stress.
Increased ROS levels modulate transcription factor activity,
especially NF-κB, activator protein-1 (AP-1) and the peroxisome
proliferators-activated receptor (PPAR) family of transcriptional
activators (Elahi et al., 2009).
As a result of increasing ROS generation, one of the
first events in atherogenesis, as well as in other CVDs
correlated with endothelial dysfunction, is the oxidative
modification of low-density lipoprotein (LDL) (Singh
et al., 2002; Perrotta and Aquila, 2015). Indeed, both
cell membranes and LDL, enriched with phospholipids,
are highly sensitive to oxidative modification. Oxidized
phospholipids, through receptor-mediated or receptor-
independent pathways, can therefore then activate endothelial
cells, induce endothelium adhesion molecules expression,
attract monocytes, have endothelium cytotoxic effects,
and increase proinflammatory gene activity and cellular
growth factors (Esper et al., 2006). All of these processes
provoke endothelial dysfunction, platelet aggregation, and
metalloproteinase expression and favor thrombogenesis
(Esper et al., 2006).
In atherosclerotic plaque, increased matrix metalloproteinase
expression and activity triggered by oxidative stress lead to its
rupture and consequent thrombosis (He and Zuo, 2015). The
NF-κB activity in atherosclerosis is mainly due to oxidized LDL
(Singh et al., 2002). At the same time, upregulated NF-κB is
detected in smooth muscle cells, endothelial cells, macrophages
and T cells of atherosclerotic plaques (Mach et al., 1998).
In the blood vessel wall, all layers can produce ROS under
pathological conditions, and most of them are primarily derived
from NOX (Reid, 2001). Due to increased ROS levels, NO
bioavailability is decreased, and consequently, endothelium-
dependent relaxation is reduced (Chen J.Y. et al., 2018).
Cardiac myocytes have a more significant number of
mitochondria than other cells and use higher oxygen levels
for energy production in the form of ATP. In myocytes,
ROS trigger cardiac injury, both oxidizing essential proteins
for excitation-contraction and decreasing NO bioactivity
(Hare and Stamler, 2005).
In myocardial ischemia, mitochondrial electron transport is
imbalanced, leading to ATP depletion, acidosis, mitochondrial
depolarization, intracellular Ca2+ overload and, then, apoptosis
(Wattanapitayakul and Bauer, 2001). Furthermore, oxidative
stress produced in mitochondria induces mitochondrial DNA
(mtDNA) damage and leads to CVD. In myocardial ischemia,
hypoxia and reoxygenation trigger an increase in free radical
production in cardiac tissue (Elahi et al., 2009). ROS produced
during reoxygenation cause direct oxidative damage to cellular
components and lead to indirect damage through the activation
of localized inflammation (Gutteridge and Halliwell, 2000). In
heart failure, excessive ROS production is based on increased
activity of XOR and NOX (Battelli et al., 2014b). Increased
ROS production is a consequence of prolonged endoplasmic
reticulum stress and mitochondrial-derived oxidative stress in
cardio-metabolic disorders.
The function of these organelles is correlated with Ca2+
release and uptake and, as a result of oxidative stress, abnormal
Ca2+ handling may cause arrhythmias. Furthermore, some
disturbance in these organelles activates signaling pathways
that alter cardiac ion channels function or expression, involved
in the generation of an action potential that promotes
arrhythmogenesis (Tse et al., 2016).
The administration of cytostatics to humans is followed
by cardiotoxicity due to increased plasma levels of ROS and
lipid peroxidation products and decreased plasma and tissue
levels of antioxidants. Myocardial changes that occur after
treatment include: myocyte loss through apoptosis or necrosis,
loss of myofibrils, distension of the sarcoplasmic reticulum, and
mitochondrial ballooning. Recent studies on transgenic mice
have shown that in cardiotoxicity induced by Doxorubicin, free
radicals can be counteracted by metallothionein and liensinine
(Kang, 1996; Liang et al., 2020).
ROS and Cancers
Cancer development in humans is a complex process that
includes cellular and molecular changes mediated by various
endogenous and exogenous stimuli (Docea et al., 2012; Sani et al.,
2017; Mishra et al., 2018). It has been established that oxidative
DNA damage is one of the key characteristics of carcinogenesis
(Smith et al., 2016). Cancer initiation and promotion are
associated with chromosomal defects and activation of oncogenes
by free radicals (Glasauer and Chandel, 2014). A common
form of injury is the formation of hydroxylated DNA bases,
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considered an important event in chemical carcinogenesis.
They interfere with healthy cell growth by causing genetic
mutations and altering normal gene transcription. Oxidative
lesions also produce many changes in the structure of DNA
(Li et al., 2015).
ROS involvement in a different stage of carcinogenesis has
been shown in various model systems. Excessive amounts of these
free radicals can lead to cell damage and apoptosis. Many forms
of cancer are considered to be the result of free radicals and DNA
reactions, leading to mutations that can affect the cell cycle and
lead to neoplasia (Pizzino et al., 2014, 2017).
ROS overproduction has an impact on cancer cell
proliferation, metastatic potential, and it is associated
with invasiveness and poor prognosis (Liou et al., 2016).
ROS contributes to cancer cell migration through various
mechanisms: (i) matrix degradation, (ii) cell-cell contact, (iii)
cytoskeleton remodeling, regulation of gene expression, (iv)
invadopodia formation (Pizzino et al., 2014).
For example, mitochondria-derived ROS has an impact
on initial extracellular matrix contact, NOX-derived ROS are
involved in invadopodia formation. At the same time, ROS
increase in cytosol plays a significant role in cytoskeleton
remodeling (Herrera et al., 2004). The effect of ROS on cancers
depends on the type of organ, as well as on the grade of
disease progression.
Skin carcinogenesis and exposure to UVA: the ultraviolet
component A sunlight (UV-A with the wavelength 320–400 nm)
has the potential to generate oxidative stress in cells and
tissues, so that endogenous and exogenous antioxidants strongly
influence the biological effects of UVA (Sage et al., 2012).
The physiological doses of UVA determine the expression
of some genes (collagenase, hem oxygenase-1, and nuclear
oncogenes), whose effects can be significantly increased by
removing intracellular GSH or by increasing the lifetime
of molecular oxygen. Repeated exposure of human skin to
UV radiation leads not only to skin carcinogenesis but also
to photo-aging through DNA damage (Cortat et al., 2013;
Saha et al., 2017).
Hydroxyl radicals can bind to DNA and produce 8-OH
deoxyguanosine (8-OHdG), which consequently increases the
risk of mutation. 8-OHdG can also initiate cancer-inducing
mutagenesis by transforming GC pairs to TA pairs during
DNA replication (Sova et al., 2010). Therefore, 8-OHdG
molecules may be used as indicators for free radicals’ detection
during DNA mutagenesis (Forcados et al., 2017). Additionally,
increased cancer cell proliferation requires high ATP levels
that lead to ROS accumulation, particularly at initial stages of
cancer genesis.
In cancer cells, there is the condition of constant oxidative
stress induced by mitochondrial dysfunction and metabolic
changes. In fact, under normal circumstances, increased ROS
levels stimulate cell death, but cancer cells overcome that by
activating numerous oncogenes, which then induce nuclear
factor erythroid 2-related factor 2 (NRF2) expression. NRF2
is the primary regulator of cell survival that raises cancer
progression by protecting cancer cells from ROS and DNA
damage (Jaramillo and Zhang, 2013).
ROS are implicated in cancer progression, promoting cyclin
D1 expression, extracellular signal-regulated kinase (ERK)
and JUN N-terminal kinase (JNK) phosphorylation, and
MAPK activation (Saha et al., 2017). However, cancer cells
enable proliferation, avoiding ROS-induced apoptosis, despite
high mutagenesis.
In neoplastic disorders, ROS promote protein oxidation
and lipid peroxidation. Moreover, ROS trigger toxic protein
carbonyls formation which has a significant impact on other
proteins or lipids (Benfeitas et al., 2017). In addition, as a
result of lipid peroxidation, cancer cells accumulate products,
such as 4-hydroxy-2-non-enal, one of the most studied
products of phospholipid peroxidation, owing to its reactivity
and cytotoxicity.
ROS and Neurodegenerative Disorders
In the brain, not all neuronal groups are equally sensitive to
oxidative stress. For instance, neurons with longer axons and
multiple synapses require more energy for axonal transport
or long-term plasticity (Salehi et al., 2019c; Tsatsakis A.
et al., 2019). High ATP demand, in combination with
dysfunctional mitochondria, make these neuron groups more
sensitive to degeneration (Wang and Michaelis, 2010). Correctly,
dopaminergic neurons are exposed to additional oxidative stress
produced by the dopamine metabolism, generating H2O2 and
dopamine autoxidation, which generates superoxide (Delcambre
et al., 2016; Buga et al., 2019).
Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral
sclerosis and Friedreich’s ataxia comprise the most common
neurodegenerative disorders (Reddy, 2009; Nussbaum et al.,
2017; Salehi et al., 2020a). During aging, mutations in
mtDNA accumulate, cytosolic calcium dysregulates, and ETC
function decreases, making aging one of the major risk factors
contributing to neurodegeneration (Payne and Chinnery, 2015).
The oxidized molecules of DNA, proteins and lipids found in
the brain tissue of post-mortem patients with neurodegenerative
disorders highlight the role of oxidative stress in these diseases
(Sharifi-Rad M. et al., 2020). Another cause of neurodegenerative
diseases is a defective use of metals by the brain, by the
intervention of mutant proteins, formed as a result of oxidative
stress (Niedzielska et al., 2016). In the case of Alzheimer
disease, a protein called amyloid beta (Aβ), consisting of 40
amino acid residues, is present in all the cells of the body,
under normal, harmless and even beneficial conditions, as
it is a natural antioxidant (Danielson and Andersen, 2008;
Li et al., 2013). It has been found that in modified protein
formations Aβ plaques, which are formed in the case of
Alzheimer’s disease outside the affected neurons, in areas that
control cognitive functions, quantities of three, up to four
times higher than normal copper, zinc and iron are fixed
(Riederer et al., 1989).
One explanation is the accumulation in the brain of a
modified form of the Ab protein (consisting of 42 amino
acid residues), which fails to properly bind metals, promotes
oxidative processes; by reacting in self-defense, neurons produce
antioxidants in increased quantities, including the modified
form of the Aβ protein, which thus becomes an antioxidant
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pro-oxidant, amplifying oxidative disasters by initiating chain
reactions (Danielson and Andersen, 2008).
Mutations of the superoxide dismutase 1 (SOD1) protein
have been linked to another neurodegenerative disease
that affects motility (familial amyotrophic lateral sclerosis)
(Huai and Zhang, 2019).
In its unmodified form, SOD1 is a natural antioxidant that
prevents the formation of peroxide anion as a dangerous reactive
form of oxygen (Saccon et al., 2013).
The mutant forms of this protein fixate a much smaller
amount of metals than the usual form, which results in the
formation of an excess of peroxynitrite (ONOO−) affecting the
motor neurons required for normal functioning, causing severe
motor disorders (Pasinelli et al., 2004).
The excessive use of glucose for energy production makes the
brain especially susceptible to oxidative stress, and mitochondrial
ETC is the primary ROS source (Cobley et al., 2018). Most
of the ROS present in the brain derive from mitochondrial
ETC complex I and III (ETC I and III), as O2− by-products
(Andreyev et al., 2005).
Monoamine oxidase (MAO) is also a great source of
ROS, especially in Parkinson’s. Indeed, the main targets for
mitochondria-generated ROS are mitochondrial permeability
transition pore (MPTP), poly (ADP-ribose) polymerase (PARP),
and mtDNA (Gandhi and Abramov, 2012).
Other oxidant sources arise from NADPH oxidase, present
in astrocytes, microglia and neurons, while NOS inhibition has
shown neuroprotective effects (Abramov et al., 2005).
In the pathogenesis of neurodegeneration, many processes
are included, such as protein misfolding and aggregation,
abnormal kinase-signaling pathways, neuronal calcium
dysregulation, and even impaired synaptic transmission
(Gandhi and Abramov, 2012). Detached abnormally aggregated
proteins that are morphologically characteristic of many
neurodegenerative diseases in neurons and/or glial cells, as
well as the rupture of metal ions homeostasis, are highly
associated with oxidative stress (Chen et al., 2012). Mechanisms
of action of ROS: these affect proteins by modifying them
in oxidative forms, which tend to form aggregates (Blokhuis
et al., 2013). Protein aggregates then inhibit proteasomes,
the main organelles in the cell for degradation of abnormal
proteins (Chen et al., 2012; Takalo et al., 2013). Accumulation
of modified proteins with an inability to be destroyed in
the proteasome stimulate more ROS formation and form a
vicious cycle, a phenomenon included in neurodegenerative
diseases related to oxidative stress (Chen et al., 2012;
Takalo et al., 2013).
ROS, Diabetes, and Metabolic Syndrome
Many metabolic contexts can lead to conditions of oxidative
stress. A condition in which oxidation is an important
pathogenetic link is type 2 diabetes. In this disease, insulin
resistance is the basic component, to which a compensatory
hypersecretion of insulin is linked. Reactive oxygen species can
induce inactivation of signaling mechanisms between insulin
receptors and the glucose transport system, leading to insulin
resistance (Chen X.F. et al., 2018).
On the other hand, diabetes itself is a generator of oxidative
stress, with atherogenetic consequences. Hyperglycemia induces
the generation of superoxide ions in endothelial cells at
the mitochondrial level. In diabetes, electron transfer and
oxidative phosphorylation are decoupled, resulting in the
production of superoxide anions and inefficient ATP synthesis.
Therefore, preventing the damage caused by oxidation is a
therapeutic strategy in diabetes. Increased levels of free fatty
acids with consecutive accumulation of intramyocellular lipids
were thought to be the cause of insulin resistance and beta-
pancreatic cell death.
Studies have shown that both glucose and free fatty acids
can initiate the formation of free radicals through mitochondrial
mechanisms and NADPH oxidase in muscles, adipocytes, beta
cells and other cell types. Free fatty acids penetrate cellular
organs, including mitochondria, where high levels of reactive
oxygen species can cause peroxidation and damage. Recent
studies show that type II diabetes and insulin resistance are
associated with a decrease in mitochondrial oxidative function
in skeletal muscle. Moreover, in this type of diabetes, the
mitochondria are smaller, rounder and more likely to produce
superoxide. Disorders of the mitochondrial transport chain,
excessive generation of reactive species and lipoperoxides, as well
as decreases in antioxidant mechanisms have also been observed
in diabetes and obesity.
Diabetes has a number of complications over time, of
which macrovasculopathy is very important. The increase in
cardiovascular risk in patients with diabetes can be explained by
the association between diabetes hypertension, dyslipidemia and
coronary atherosclerotic disease. However, other mechanisms are
also involved, such as the effects of hyperglycemia on endothelial
function, the effects of glucose and fatty acids on myocardial cells,
at the structural level but also of gene expression (Aroor et al.,
2012; Karam et al., 2017).
Diabetic cardiovascular complications are caused by impaired
cardiac microvascular function. In addition to the structural and
functional changes that occur in diabetic cardiomyopathy,
other mechanisms can be targeted pharmacologically.
Sodium-glucose co-transporter-2 (SGLT2) inhibitors are
the first class of antidiabetic drugs that have reduced the
risk of heart failure in type 2 diabetes (Karam et al., 2017).
Empagliflozin has an indication to reduce cardiovascular
mortality in patients with diabetes and atherosclerotic
disease. A recent study demonstrated the beneficial effect
of empagliflozin on cardiac microvascular injury in diabetes
and the protective mechanism against oxidative stress in
mitochondria (Zhou et al., 2018).
Another recent study showed that aminoguanidine has
a beneficial effect on diabetes-induced heart abnormalities.
Aminoguanidine saves contractile abnormalities and diabetes-
induced cardiac remodeling. This was explained by inhibition
of endoplasmic reticulum stress and induction of autophagy
(Pei et al., 2018).
Insulin resistance, abdominal obesity, atherogenic
dyslipidemia, endothelial dysfunction, high blood pressure,
hypercoagulability, genetic predisposition and chronic stress
are the main factors underlying the metabolic syndrome.
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Metabolic syndrome is often characterized by oxidative
stress, a condition in which there is an imbalance between
the production and inactivation of reactive oxygen species.
Increased generation of reactive oxygen species, decreased
activity of antioxidant systems or both mechanisms
may be involved in the occurrence of oxidative stress
(Karam et al., 2017).
A study showed that lenalidomide attenuates oxidative
cardiovascular tissue damage and apoptosis in obese mice by
inhibiting tumor necrosis factor (Zhu et al., 2014).
ROS and Aging
Postulated over 60 years ago, the “free radical theory of aging”İ
pointed to ROS as a cause of damage accumulation in cell
constituents and connective tissues. This accumulation of losses
in cells would be the reason for aging and aging-associated
degenerative diseases (Tsoukalas et al., 2019a). Aging can be
caused by both genetic and external factors, such as incorrect
diet, improper physical exercise, chronic drug use, untreated
inflammatory conditions, smoking, and alcohol abuse.
Today, while there are several theories of aging, the basic
principle of most of them is still oxidative stress (Finkel
and Holbrook, 2000; Payne and Chinnery, 2015). The major
systems involved in overproduction of oxidative stress in cells
are mitochondria and NOX (Bedard and Krause, 2007). NOX
comprises a family of several membrane-associated enzymes,
located in mitochondria of many cell types, and it has been shown
in different studies that its enhanced activity and/or expression is
included in age-associated diseases (Zhang et al., 2004; Park et al.,
2008; Egea et al., 2017).
In the aging process, it has been noticed that high-molecular
protein aggregates accumulate in cells (Davalli et al., 2016).
Predominantly, these aggregates are made from proteins, with
the remainder consisting of various lipids (Barrera, 2012;
Takalo et al., 2013; Tsoukalas et al., 2019b). Most of the
proteins aggregated are oxidized/modified by different reactive
metabolites, and they could bind to cellular proteins. Thus,
the crucial point for protein homeostasis maintenance is the
degradation of these aggregates.
The central place for cell damaged protein degradation
is the proteasome, which recognizes only unfolded proteins
as degradation targets (Saez and Vilchez, 2014). Proteasome
inhibition prevents further degradation of newly formed oxidized
proteins and increases protein aggregation formation in cells
(Takalo et al., 2013; Saez and Vilchez, 2014). Besides that,
proteasome becomes dysfunctional during aging.
While proteasomal dysfunction is correlated with age
progression and protein aggregation, proteasome activation
slows the aging progress down and increases longevity
(Chondrogianni et al., 2014). In many invertebrate models
and cell lines, it has been shown that the overexpression
of different proteasomal regulatory or catalytic subunits or
treatment with specific compounds has positive effects on
proteasome activity (Saez and Vilchez, 2014).
Along with the “free radical theory of aging” popularization,
İthis has started the trend of antioxidant supplement
consumption (Conti et al., 2016). Recently, most of the data have
indicated that antioxidant supplementation does not decrease
the incidence of age-related diseases (Schottker et al., 2015).
ANTIOXIDANT DEFENSES
Antioxidants break radical chain reactions, preventing oxidative
stress-related damage (Da Pozzo et al., 2018; Figure 2).
Their role requires acting both in hydrophilic and
hydrophobic cellular environments, so their chemical structure
is quite heterogeneous.
There are enzymatic and non-enzymatic antioxidants
(Banafsheh and Sirous, 2016), as shown in Figure 1. but, from a
nutritional perspective, a more informative classification can be
made between endogenous and exogenous classes.
The first class comprises all antioxidants that cells can
synthesize from smaller building blocks. Accordingly, all
enzymatic antioxidants are endogenous, as well as some
non-enzymatic ones (i.e., thiols antioxidants and coenzyme
Q10, Figure 3).
On the contrary, exogenous antioxidants have to be ingested
through the diet, since their synthesis is impossible in eukaryotic
cells. So, particular attention should be paid on this latter
class, since this is the most unpredictable component in
cellular redox balance.
Antioxidants can be divided into two categories
depending on their solubility: water soluble and liposoluble
(Lazzarino et al., 2019).
Water soluble antioxidants are best absorbed in the
body because the vegetables and fruits that contain such
antioxidants, also contain water. On the other hand, they are
rapidly eliminated from the body through the urine. Water-
soluble antioxidants include polyphenols, but also vitamin C
(Lazzarino et al., 2019).
Liposoluble antioxidants, fat-soluble antioxidants are those
that are absorbed in the presence of fats. Therefore, in the absence
of fats, the body cannot absorb and use these antioxidants. It
is important to note, however, that they are not easily removed
from the body and can accumulate over time, exceeding the
healthy level. Vitamin E is an example of a fat-soluble antioxidant
(Lazzarino et al., 2019).
Enzymatic Antioxidants
Several enzymes obstruct free radicals’ formation, some of them
act directly in scavenging ROS (primary enzymes), whereas
“secondary enzymes” play an indirect role by supporting other
endogenous antioxidants (Banafsheh and Sirous, 2016). This is
the case, for instance, for glucose-6-phosphate dehydrogenase
that regenerates NADPH, essential for primary enzyme
action (Figure 2).
Primary Enzymes
Primary enzymes act directly on the main ROS arising from
incomplete O2 reduction, O2− and H2O2. SOD scavenges
the former, whereas CAT and GPX remove the latter. SOD
(E.C. 1.15.1.1) is a metalloenzyme, catalyzing superoxide anion
dismutation to H2O2 and molecular oxygen, as shown in reaction
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FIGURE 2 | Schematic figure of the link between ROS, oxidative stress and their effects on the human body. Oxidative stress is the imbalance that occurs when
there is an increased production of free radicals that exceeds the body’s ability to neutralize it. Alteration of chemical reactions at the cellular level leads to the
appearance of free radicals and peroxides that affect the intracellular structures – proteins, lipids, DNA, with the disruption of intrinsic mechanisms at this level. Free
radicals are normally produced in the body due to the influence of external factors, such as pollution, cigarette smoke, or internal, due to intracellular metabolism
when antioxidant mechanisms are exceeded.
FIGURE 3 | Primary enzymes (SOD or peroxidases) act directly in scavenging ROS. Secondary enzymes, such as glutathione reductase and glucose-6-phosphate
dehydrogenase, support the action of primary enzymes regenerating NAPDH and reduced glutathione.




→ H2O2 + O2 (1)
SODs can be divided into four groups, with different
metal cofactors. Copper-zinc SOD is most abundant in
chloroplasts, cytosol and extracellular space. Iron SOD is found
in plant cytosol and in microbial cells, whereas manganese
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SODs are mitochondrial (Perera et al., 2017). SOD also
competes for superoxide anion with NO. Therefore, SOD
also indirectly reduces the formation of another deleterious
ROS, peroxynitrite (ONOO−, reaction 2), and increases
the NO biological availability, an essential modulator for
endothelial function.
O−2 · +NO· → ONOO
− (2)
CAT (E.C. 1.11.1.6) is a tetrameric ferriheme oxidoreductase,
which catalyzes H2O2 dismutation to water and gaseous oxygen,
as shown in reaction 3 (Grigoras, 2017).
2H2O2
CAT
→ 2H2O+ O2 (3)
CAT is mainly located in peroxisomes, and despite being
ubiquitous, the highest activity is present in liver and red
blood cells. CAT works with a two-step mechanism, somewhat
resembling the formation in the first step of a peroxidase-like
compound I intermediate, CpdI (reaction 4) (Alfonso-Prieto
et al., 2009; Zucca et al., 2014), which in turn decomposes to





















A NADPH molecule is bound to each subunit, minimizing
H2O2–mediated inactivation [105]. CAT is one of the enzymes
with the highest known kcat(more than 106 s−1) in all known
proteins, close to a diffusion-controlled reaction (Tovmasyan
et al., 2015). The role of CAT versus peroxynitrite has been much
debated, but recent advances suggested CAT’s ability to scavenge
ONOO− (Gebicka and Didik, 2009).
GPX (E.C. 1.11.1.19) is a selenium-dependent oxidoreductase,
which uses H2O2 or organic hydroperoxide as the oxidant, and
the tripeptide GSH as the electron donor (Cardoso et al., 2017),
in a typical class I peroxidase catalytic cycle (reactions 6 and 7).
H2O2 + 2GSH
GPx
→ 2H2O+ GS− SG (6)
ROOH + 2GSH GPx→ ROH +H2O+ GS− SG (7)
The GPX family is composed of eight isoenzymes (GPX1-
8). Each enzyme presents peculiar features. GPX1, 2, 3, and 4
incorporate selenocysteine (a non-standard amino acid, where
the sulfur atom of cysteine is replaced by selenium). GPX6
contains selenium only in humans, but not in rodents; whereas
GPX5, 7, and 8 do not have selenium, but a “normal” cysteine
instead (Cardoso et al., 2017).
During the catalytic cycle, selenocysteine is converted
from selenol (Enz-SeH) to selenenic acid (Enz-SeOH), with
concomitant reduction of H2O2 or ROOH. Then, the first GSH
molecules yield selenenyl sulfide intermediate (Enz-Se-SG). An
incoming second GSH molecule attacks Enz-Se-SG, regenerating
the enzymatic resting form Enz-SeH, releasing the oxidized and
dimerized GSSG (Cardoso et al., 2017).
Another important class of enzymatic peroxide scavenger
is PRDX. Six different classes of PRDX have been identified
(Poole and Nelson, 2016), showing either one (1-Cys PRDX) or
two (2-Cys PRDX) redox-active cysteine residues (Park et al.,
2016). The PRDX catalytic cycle involves H2O2 decomposition
and the subsequent regeneration of the resting enzyme, using
a small cysteine protein thioredoxin (Trx) as the reductant
(reactions 8 and 9). Trx shows two vicinal cysteines (in the
typical CXXC motif), forming, in turn, a disulfide internal bridge
upon oxidation. In the case of PRDX6 isoform, Trx can be
replaced by GSH.
RDXreduced +H2O2 → PRDXoxidized + 2H2O (8)
PRDXoxidized + Trxreduced → PRDXreduced + Trxoxidized (9)
Secondary Enzymes
All the enzymatic activities described above rely on the
continuous regeneration of the reduced form of reductants
(mainly GSH and Trx). This is usually performed by some
reductases, NADPH-dependent (such as glutathione reductase
E.C. 1.8.1.7 and thioredoxin reductase E.C. 1.8.1.9). However,
as shown in Figure 2, reduced NADPH is, in turn, needed
by these reductases for their continuous action. So, enzymes
responsible for the constant NADPH production can be
considered secondary antioxidants, as their misfunction could
affect the whole ROS balance. The main NADPH metabolic
source is the pentose phosphate pathway, through the first two
enzymatic activities: glucose-6-phosphate dehydrogenase (E.C.
1.1.1.49) and 6-phosphogluconate dehydrogenase (E.C. 1.1.1.44).
However, other contributions come from the malic enzyme (E.C.
1.1.1.40) and a recently identified folate-dependent mechanism
(Fan et al., 2014).
Non-enzymatic Antioxidants
Some chemical molecules of low-molecular-weight can also
directly act as antioxidants. In this case, their action is not
catalytic, always needing antioxidant regeneration or its supply
from the diet. Non-enzymatic antioxidants can therefore be
divided into endogenous (if the eukaryotic cell is able to
synthesize it) and exogenous (if the antioxidant needs to be
ingested mandatorily through the diet).
Endogenous Non-enzymatic Antioxidants
Both GSH and Trx can act also act potent ROS scavengers
(including ·OH, H2O2, organic peroxides, and ONOO−) directly,
without enzymatic help.
GSH (γ-glutamyl-cysteinyl-glycine, Figure 4) is a tripeptide,
mainly distributed in cytosol, but also in nuclei, peroxisomes
and mitochondria. Despite being ubiquitous, the liver is the
leading site for its synthesis (Banafsheh and Sirous, 2016).
GSH biosynthesis is an endergonic process (ATP hydrolysis
is coupled), in which firstly glutamate and cysteine condense
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FIGURE 4 | Glutathione (GSH), a tripeptide with an active –SH function. GSH
undergoes a redox cycle, dimerizing with a disulfide bridge formation.
to yield γ-glutamylcysteine (reaction catalyzed by glutamate-
cysteine ligase, E.C. 6.3.2.2). This unusual γ-peptidic bond
protects it from the common peptidases action. In the final
step, GSH synthetase (E.C. 6.3.2.3) adds a glycine residue to the
α-amino group of cysteine (Hasanuzzaman et al., 2017).
α-Lipoic acid (1,2-dithiolane-3-pentanoic acid, Figure 4) is a
disulfide compound that undergoes a redox cycle similar to GSH.
Accordingly, it scavenges reactive ROS, and regenerate vitamins
C and E, and GSH in their active forms (Kucukgoncu et al.,
2017). Lipoic acid also has a role in metal chelation, preventing
Fenton-like radical reactions (Zhang and McCullough, 2016).
Nevertheless, even small proteins, such as Trx and glutaredoxin
can similarly function as thiol antioxidants, showing redox-active
mono- or di-cysteine motif (CXXC). Both proteins can be in turn
reduced back to their active form, directly by GSH or indirectly
by NADPH (Banafsheh and Sirous, 2016).
Melatonin (N-acetyl-5-methoxytryptamine, Figure 5) is a
neurohormone derived from amino acid tryptophan. It is
involved in circadian rhythms but also acts as a potent
antioxidant, protecting cell membranes against lipid peroxidation
(Beyer et al., 1998).
It has been described to be more effective in ROS scavenging
than vitamin E, GSH, vitamin C and β-carotene (Watson, 1998).
Coenzyme Q10 or ubiquinone (2,3-dimethoxy-5-methyl-6-
polyisoprene parabenzoquinone, Figure 5) is an isoprenoid
antioxidant present in cell membranes, essential for ETC
(Tafazoli, 2017). Its synthesis starts from oligomerization of
isoprenoid building blocks, isopentenyl pyrophosphate and
dimethylallyl pyrophosphate (both arising from the mevalonate
pathway and the key enzyme 3-hydroxy-3-methyl-glutaryl-CoA
reductase (E.C. 1.1.1.88). The resulting decaprenyl diphosphate is
then conjugated with a tyrosine derivative to yield the active form
of the coenzyme. It is one of the few liposoluble antioxidants,
ensuring lipoproteins and lipids protection from radical chain
reactions, peroxidation and oxidative damage (Lee et al., 2017). In
its active form (quinol), coenzyme Q10 can scavenge several ROS
or regenerate other oxidized antioxidants (including vitamins C
and E). In turn, the quinone form can be reduced back by several
NAD(P)H-dependent enzymatic systems.
Exogenous Non-enzymatic Antioxidants
Exogenous antioxidants need to be supplemented continuously
through the diet since their synthetic pathways are usually
present only in microbial or plant cells. Vitamins, two of which
show prominent antioxidant effects, such as vitamins C and E,
belong to essential class of molecules.
Vitamin C (ascorbic acid) exists in two redox forms: ascorbic
acid (AA) is the reduced form, which is deprotonated at
physiological pH (thus, occurring in its anion form, ascorbate).
Due to its high electron-donating power, AA can undergo
two-electron oxidation, yielding dehydroascorbic acid (DHA).
One-electron oxidation of AA is also possible, generating a
semi-dehydro-ascorbyl radical (Kocot et al., 2017). DHA can
be regenerated to the active AA form by GSH- or Trx-
dependent mechanisms. Humans do not express the enzyme
L-gulonolactone oxidase (E.C. 1.1.3.8), avoiding the possibility
of endogenous synthesis. Thus, AA must be ingested by food
(or supplements), particularly tomatoes, pineapples, watermelons
and all citrus fruits (Banafsheh and Sirous, 2016). AA effectively
quenches ROS, both directly and cooperatively regenerating
oxidized vitamin E, GSH, and carotenoids. Scavenged ROS can
be superoxide anion, 1O2, H2O2, organic peroxides, •OH or
hypochlorous acid (HClO).
Vitamin E is a fat-soluble vitamin, mostly found in several
vegetable oils, nuts, broccoli and fish. Eight different forms
have been reported (α-, β-, γ-, and δ-tocopherol, and α-,
β-, γ-, and δ-tocotrienol), but α-tocopherol has the highest
antioxidant activity, especially in cell membranes (Salehi
et al., 2020b). A variously methyl-substituted chromanol ring
characterizes tocopherols. A long phytyl chain gives the
hydrophobicity (Figure 6).
On the contrary, tocotrienols bear an unsaturated isoprenoid
chain. α-Tocopherol is able to undergo hydrogen transfer to
several ROS, including 1O2, superoxide anion and peroxyl
radicals. The oxidized and radical derivative of vitamin E is then
reduced by the AA.
Carotenoids are a broad class of tetraterpenes, widely
distributed among plants. Carotenoids are divided into
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FIGURE 5 | Chemical structures of Lipoic acid, Melatonin, Coenzyme Q10.
FIGURE 6 | Chemical structures of Vitamin C, Curcumin, Resveratrol, Quercetin, Vitamin E, β-carotene, Lycopene.
unoxygenated “carotenes.” On the contrary, if oxygen atoms
are present, “xanthophylls” is the correct term (Meybodi et al.,
2017). Carotenes are also vitamin A precursors. Carotenoids
protect plant chlorophyll, acting as accessory pigments during
photosynthesis. Thus, they are intensely colored (red, orange, or
yellow) molecules.
Carotenoids have been suggested to be chemopreventive
agents in cancer (Marti et al., 2016; Salehi et al., 2019a),
even if the real effect is still debated (Panic et al., 2017).
Their biological activities also include ROS scavenging
(Hernández-Almanza et al., 2016; Salehi et al., 2019b).
β-Carotene comprises one of the most diffused carotenes,
being the primary pro-vitamin A precursor, and it is found
mainly in carrots, pumpkins, mangoes and apricots. Lycopene
is another well-known acyclic carotene, not being a precursor
of vitamin A, and is found primarily in tomatoes and other
red fruits, but not in strawberries and cherries. Indeed,
carotenoids are strong ROS scavengers, operating a very
particular physical and chemical 1O2 quenching (Banafsheh
and Sirous, 2016). In the physical mechanism, the carotenoid
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electron-rich structure absorbs 1O2 excess energy, reaching
an excited state. The conjugated double bond structure in
carotenoids is responsible for this ability. The excited state
then decays to the ground state, losing the surplus energy
as heat. During this cycle, the structure of this molecule
stays unchanged.
Polyphenols are a large class of plant secondary metabolites,
whose synthesis is usually possible only in these organisms
(Sanjust et al., 2008; Salehi et al., 2019a). The key enzyme
[phenylalanine ammonia-lyase (PAL), EC 4.3.1.5] is only
present in plants (Rasouli et al., 2016). PAL catalyzes the
non-oxidative deamination of phenylalanine to trans-
cinnamic acid, which is the fundamental building block
for polyphenol synthesis in the phenylpropanoid pathway
(Ertani et al., 2016). Several biological functions have
been ascribed to polyphenols, including anti-inflammatory,
antioxidant, antimicrobial and antimelanogenesis effects
(Zucca et al., 2016; Barbieri et al., 2017; Da Pozzo et al.,
2018), suggesting their use in the human diet and as food
supplements. The most widely recognized polyphenols’
classes are flavonoids, phenolic acids, stilbenes (including
resveratrol), tannins, coumarins, curcuminoids and lignans.
For instance, one of the most studied polyphenols has been
curcumin, gaining a lot of attention also for nutraceutical
applications. This phytochemical has, in fact, potent
activity as a scavenger for superoxide anions, H2O2,
lipid peroxides, •OH, and several RNS (Imam et al.,
2017). Curcumin can also increase GSH cellular levels
(Banafsheh and Sirous, 2016).
Epigallocatechin-3-gallate (EGCG) is a well-known
antioxidant. The green tea catechins include catechin,
epicatechin, epigallocatechin, epicatechin gallate, and
epigallocatechin gallate (Barbieri et al., 2017). Catechins
can react with superoxide anions and •OH, and is also able to
chelate metal ions (Imam et al., 2017; Roychoudhury et al., 2017).
Flavonoids, in addition to its strong antioxidant properties,
quench ROS formation inhibiting several enzymes and chelating
metals involved in radical chain reactions (Banafsheh and Sirous,
2016). In fact, flavonoids present shallow redox potentials,
allowing them to directly reduce highly reactive ROS with
high redox potentials, such as superoxide anion, peroxyl
radicals and •OH by hydrogen atom transfer mechanism
(HAT) (Salehi et al., 2019d). Furthermore, flavonoids
can also affect free metal ion concentrations. In the cell
environment, these can promote ROS formation reacting
with H2O2 and generating highly reactive •OH, in a series
of Fenton and Fenton-like reactions. Indeed, flavonoids
have the well-known capacity to chelate several metal ions
(such as iron and copper), blocking free radical generation
(Kumar and Pandey, 2013). For instance, quercetin is one
of the most diffused flavonols present in broccoli, apples,
grapes, onions and soybeans, with both iron-chelating and
iron-stabilizing abilities (Kumar and Pandey, 2013). On the
other hand, catechol and galloyl-derivatives are generally
well-known metal chelators (Jomova and Valko, 2011). So,
they can all exert their antioxidant activity by blocking
Fenton-like reactions.
Organosulfur compounds have also been suggested as potent
antioxidants. The most studied are probably some sulfur-
containing metabolites present in garlic (mainly S-allyl-mercapto
cysteine, S-allyl cysteine, and diallyl sulfide, diallyl trisulfide)
(Kimura et al., 2017). These organosulfur are also responsible
for typical garlic flavor. Their antioxidant actions include
scavenging ROS and inhibiting lipids peroxidation (Borek, 2001;
Miltonprabu et al., 2017).
Several minerals, in small amounts, are also essential for some
enzymatic antioxidant activities. They are therefore sometimes
regarded as antioxidants themselves. For instance, selenium
is a necessary component of GPX (Battin and Brumaghim,





The balance between ROS production and purification
maintains homeostasis of the body, but is most often directed
to the formation of free radicals and involvement in the
pathophysiology of chronic diseases. The use of antioxidant
supplements containing multivitamins and minerals has always
grown in popularity among consumers. But some recent studies
have not shown any beneficial effect of antioxidant therapy.
Oxidative stress has a dual character: it is both harmful and
beneficial to the body, because some ROS are signaling molecules
on cellular signaling pathways. Lowering the level of oxidative
stress through antioxidant supplements is therefore not beneficial
in such cases (Ye et al., 2004; Ray et al., 2012).
Antioxidants are also prone to oxidation since oxidation and
reduction reactions do not happen in isolation. AA, a potent
antioxidant, mediates several physiological responses. Still, it
can also act as a pro-oxidant when it combines with iron and
copper, reducing Fe3+ to Fe2+ (or Cu2+ to Cu+), which in turn
reduces H2O2 to hydroxyl radicals (Duarte and Lunec, 2005).
This reaction is responsible for oxidative stress-produced DNA
damage. However, the role of AA as anti- or pro-oxidant depends
on the dose used, as observed in the case of ischemia-induced
oxidative stress (Seo and Lee, 2002).
On the other hand, the pro-oxidant/antioxidant activity of
β-carotene and lycopene has been reported to be dependent
on its interaction with biological membranes and other co-
antioxidant molecules, like vitamins C or E (Young and Lowe,
2001). With increased oxygen tension, carotenoids tend to lose
their antioxidant potential. Otherwise, α-tocopherol, a powerful
antioxidant, becomes pro-oxidant at high concentrations (Cillard
and Cillard, 1980). Interestingly, when it reacts with a free
radical, it becomes a radical in itself. If there is not enough AA
for its regeneration, it will remain in that highly reactive state
(Lü et al., 2010).
Flavonoids can also act as pro-oxidants depending on the
concentrations used (Prochazkova et al., 2011). Indeed, dietary
phenolics may act as pro-oxidants in the presence of O2 and
transition metals, like iron and copper, catalyzing phenolics’
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redox cycling and leading to ROS and phenoxyl radicals’
formation, with consequent damage in DNA, lipids and other
biological components (Galati and O’Brien, 2004). Nevertheless,
the extent to which these phytochemicals are capable of acting as
anti- or pro-oxidants in vivo is still poorly understood, and this
topic undoubtedly requires further research.
CLINICAL STUDIES RELATED TO
EFFICACY OF ANTIOXIDANTS IN
PREVENTION OF CHRONIC DISEASES
The hypothesis that antioxidants could protect against cancer
because they can neutralize reactive oxygen species (ROS) that
can damage DNA has long been issued. In laboratory and animal
studies, the presence of elevated levels of exogenous antioxidants
has been shown to prevent the types of free radicals that have been
associated with the development of cancer.
A few randomized studies evaluating the role of antioxidant
supplements for cancer prevention were conducted in
collaboration with the National Cancer Institute (Goodman
et al., 2011). No data were obtained to justify that they
are effective in primary cancer prevention. An analysis in
the United States concluded that there is no clear scientific
evidence for the benefits of vitamin and mineral supplements in
cancer prevention.
It is important to point out that there have been cases where
people who have resorted to these types of supplements have
encountered an unfavorable evolution of the disease. Preclinical
studies also report that antioxidants have contributed to the
expansion of tumor processes in animal models. A well-known
case is that of vitamin A, for which the administration of high
doses in supplements has been associated with an increased
risk of cancer. Vitamin A can be obtained preformed from
animal sources or plant products, derived from β-carotene.
Supplements are recommended only in special cases, at the
doctor’s advice and especially in areas where there are frequent
deficits (Jerome-Morais et al., 2011).
β-Carotene is an orange pigment found in fruits and
vegetables (carrots, sweet potatoes, mangoes, apricots), and in
the body it is converted to vitamin A. A normal intake has a
beneficial effect against the risk of cancer. However, studies have
shown a correlation between the administration of β-carotene
supplements and the risk of bladder cancer, as well as the risk of
lung cancer in smokers (Lin et al., 2009).
In another study, the administration of α-tocopherol and
β-carotene for lung cancer did not change the incidence of lung
cancer. However, α-tocopherol supplements have been shown
to be effective in prostate cancer whose incidence is reduced
(Goodman et al., 2011).
A trial evaluated the effectiveness of long-term
supplementation with vitamin E and vitamin C in the risk
of developing cancer. One of the findings of the study was that
these types of supplements do not reduce the risk of prostate
cancer or the overall risk of cancer in men of middle age or
older. No significant results were obtained regarding the risk of
colorectal or lung cancer (Gaziano et al., 2009).
Vitamin E and C supplements showed poor results in many
studies. According to a clinical study entitled Physicians’ Health
Study II conducted between 1997 and 2007, which included over
14,000 men over 50, the risk of major cardiovascular events
was not reduced by supplementation with vitamins E or C
(Lin et al., 2009).
Women’s Health Study (WHS) is another comprehensive
study in the United States involving nearly 40,000 healthy
women, with a minimum of 45 years of age who received
600 IU of vitamin E administered on alternate days, and who
were followed for a period of 10 years (Lee et al., 2005).
There was a reduction in cardiovascular mortality, but no
significant effect was observed on overall mortality. The authors
concluded that vitamin E supplementation for the prevention
of cardiovascular disease among healthy women is not justified.
Moreover, cancer mortality is not significantly influenced by
vitamin E supplementation (Lee et al., 2005).
The Selenium and Vitamin E Cancer Prevention Trial
(SELECT) which included over 35,000 men over the age of
50, showed that selenium and vitamin E supplements do not
prevent prostate cancer. In addition, a study even suggsted that
vitamin E supplements increase the risk of prostate cancer by 17%
compared to a placebo (Klein et al., 2011).
DISCUSSION
This article summarizes the evidence from a large number
of meta-analyzes covering the pathophysiological impact of
antioxidants on the most common chronic diseases. The main
criticism of the review is that the data were extracted from
meta-analyzes and not from individual studies, but this can
be considered an advantage because meta-analyzes provide the
highest degree of evidence.
In the case of antioxidants, studies show that more does
not necessarily mean better. Consuming superfoods does not
compensate for other unhealthy eating habits or an unbalanced
lifestyle. Free radicals, as well as antioxidants, can have beneficial
effects on the body. Therefore, we are talking about a balance and
not a negative role attributed to free radicals and a positive one
to antioxidants.
Degradation of nucleic acids, proteins, lipids or other cellular
components are among the effects that an excessive concentration
of free radicals can generate. Many diseases that are intensely
discussed today are associated with the influence of oxidative
stress – cancer, cardiovascular disease, Alzheimer’s disease,
autoimmune diseases. Risk factors leading to free radicals
include air pollution, ionizing radiation, prolonged exercise,
infections, excessive consumption of polyunsaturated fatty acids
(Poprac et al., 2017).
On the other hand, antioxidants are considered to be the
solution to these problems – substances that neutralize free
radicals. In reality, the term “antioxidant” refers to a chemical
property of a substance to donate electrons. In some situations,
some substances act as antioxidants, in other situations they
become prooxidants, depending on the chemical composition
of the environment in which they are. There are many types
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of antioxidants, and the role in the body and the mechanisms
by which they act are different. One misconception is that
one antioxidant can be replaced with another, having the same
effect. In fact, each has its own unique biological properties
(Chen X.F. et al., 2018).
There is also a significant difference between taking
antioxidants from food and administering an isolated
substance as a supplement. Many substances that demonstrate
beneficial effects in the laboratory do not work when
introduced into the human body. Many antioxidants
do not have good bioavailability. The concentration of
antioxidants such as polyphenols is sometimes so low in
the blood that no significant effect is observed (Fernández-
García et al., 2012). Fruits and vegetables contain bioactive
substances that in many cases do not work as antioxidants
if we consider them outside of the body. But they work
as antioxidants when they are in the body, because they
activate their own antioxidant mechanisms. These bioactive
substances are the secret behind vegetable consumption
(Kurutas, 2015).
Antioxidant supplements may have different health benefits.
On the one hand, it is possible that other substances present
in food are responsible for the positive effects on health, not
necessarily a certain type of antioxidant, but the synergistic effect
of several substances. On the other hand, the chemical structure
of antioxidants in food is often different from that identified in
supplements. An example is vitamin E. There are eight variants
of vitamin E in the foods we eat, while the supplements used in
most studies contain only one form (Firuzi et al., 2011).
Studies also frequently include healthy people, for whom
oxidative stress on the body is not significant to determine a risk
of disease. Antioxidants can benefit certain categories of patients
in whom there is a real, documented imbalance, but it may not
bring anything extra for a person who gets a sufficient amount of
nutrients from their diet.
Observational studies analyze the trends, or habits of certain
large population groups. In many, all the risk factors that
could influence the course of the study can be controlled,
and demonstrating a cause-effect relationship is difficult. We
also cannot rely on small studies, carried out over a short
period of time and using very concentrated substances extracted
from different plant or animal products, to say that we have
a superfood. Nutrition is a complex science, and at the
moment we can only rely on the evidence accumulated so




Oxidative stress can be reduced by approaching a balanced
lifestyle. Nutrition plays a critical role, and the best treatment
against oxidative stress is antioxidants. Oxidative stress plays
an important role in the pathogenesis of potentially severe
conditions. In the long term, increasing the level of prooxidant
factors can cause structural defects in mitochondrial DNA and
alterations in enzymatic functionality or cellular structures,
with the appearance of functional, structural abnormalities or
aberrations in gene expression. It has also been shown that
in addition to metabolic products, other external agents can
have a prooxidant effect, which has led to the conclusion that
lifestyle and diet can play an important role in controlling
oxidative stress.
Plant-derived bioactive molecules have gained pivotal
attention in recent years, given their therapeutic relevance in
both disease prevention and treatment, whether using the whole
plants, plant extracts or even the isolated constituents with full
phytochemical profiles. The daily intake of a wide variety of
phytochemicals has shown to be chemopreventive. It might hold
promise for add-on treatment for several diseases, including
cancer, diabetes, cardiovascular disease and neurodegenerative
disorders. Larger randomized trials are needed to obtain clear
scientific evidence on the benefits or risks of antioxidant
supplementation during cancer treatment.
Antioxidants are also prone to oxidation, and therefore their
use as foods (or supplements) should be carefully considered
because oxidation and reduction reactions do not happen in
isolation. The intake of high doses of antioxidants has been
increasingly highlighted since there is increasing evidence of
some detrimental effects. The study of their chemical components
as future prophylactic and therapeutic agents would be of
particular interest, as they are more effective and safer than those
widely available.
In conclusion, oxidative stress is an important pathogenetic
link for humans and studies in this field may be important
elements in the future, to better understand and manage
various diseases.
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